i have some hopes they'll do OK, since they have revenues starting to be generated from several areas, even though biotechs recently have been slammed.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025